LQDA | Liquidia Corp |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.14 |
Leverage | 56.30% |
Market Cap | $ 763.3m |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -118.8m |
Margin | 5710.42% |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.